https://doi.org/10.4081/reumatismo.2018.1062
Update on treatment of polymyalgia rheumatica
Submitted: 17 August 2017
Accepted: 8 February 2018
Published: 27 March 2018
Accepted: 8 February 2018
Abstract Views: 5449
PDF: 3247
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Camellino, D., & Dejaco, C. (2018). Update on treatment of polymyalgia rheumatica. Reumatismo, 70(1), 59–66. https://doi.org/10.4081/reumatismo.2018.1062
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca, Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis , Reumatismo: Vol. 65 No. 4 (2013)
- V. Shobha, A.M. Desai, T. Matthew, Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case , Reumatismo: Vol. 71 No. 2 (2019)
- R. Scarpa, A. Cauli, E. Lubrano, In memory of Dr. Luis Espinoza , Reumatismo: Vol. 72 No. 2 (2020)
- D. Mohamadzadeh, S. Assar, M. Pournazari, P. Soufivand, S. Danaei, Disseminated cutaneous herpes simplex infection after COVID-19 vaccination in a rheumatoid arthritis patient: a case report and review , Reumatismo: Vol. 74 No. 2 (2022)
- B. Grigolo, L. Roseti, M. Fiorini, L. De Franceschi, A. Facchini, Tissue engineering applications: cartilage lesions repair by the use of autologous chondrocytes , Reumatismo: Vol. 54 No. 4 (2002)
- A.A. Conti, D. Lippi, G.F. Gensini, The historical evolution of the concept of apoptosis in rheumatic diseases , Reumatismo: Vol. 57 No. 1 (2005)
- A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini, Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis , Reumatismo: Vol. 58 No. 3 (2006)
- L. Alcidi, E. Beneforti, M. Maresca, U. Santosuosso, M. Zoppi, Low power radiofrequency electromagnetic radiation for the treatment of pain due to osteoarthritis of the knee , Reumatismo: Vol. 59 No. 2 (2007)
- V. Bruzzese, Diffused suberitrodermic psoriasis induced by infliximab , Reumatismo: Vol. 59 No. 4 (2007)
- V. Bruzzese, J. Pepe, Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab) , Reumatismo: Vol. 61 No. 4 (2009)
<< < 55 56 57 58 59 60 61 62 63 64 > >>
You may also start an advanced similarity search for this article.
